GE Healthcare has awarded researchers $2.5 million in funding to develop PET tracer that will determine the effectiveness of immunotherapy in patients early in their treatment course.
http://news.vumc.org/2019/11/07/project-seeks-new-way-to-assess-immunotherapy-effectiveness/#new_tab
